Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
RNA polymerase | R-HSA-73864 | map03020 | ergocalciferol | 5280793 | drug-path |
Glioma | Q9NZM4 | map05214 | cisapride | 6917698 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | cisapride | 6917698 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | cisapride | 6917698 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | cisapride | 6917698 | drug-path |
Base excision repair | R-HSA-73884 | map03410 | cisapride | 6917698 | drug-path |
Bladder cancer | R-HSA-9700206 | map05219 | cisapride | 6917698 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | cisapride | 6917698 | drug-path |
Basal transcription factors | R-HSA-3232118 | map03022 | cisapride | 6917698 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | puromycin | 4633 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | puromycin | 4633 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | puromycin | 4633 | drug-path |
Circadian rhythm - mammal | R-HSA-400253 | 0 | puromycin | 4633 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | puromycin | 4633 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | puromycin | 4633 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | puromycin | 4633 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | puromycin | 4633 | drug-path |
Shigellosis | 0 | map05131 | puromycin | 4633 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | puromycin | 4633 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | puromycin | 4633 | drug-path |